Bruker Corporation

Equities

BRKR

US1167941087

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-10 pm EST			5-day change	1st Jan Change
41.58 ^USD	-1.24%		-4.96%	-11.74%

Feb. 09	Chemspeed and SciY Announce Self-Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration	CI
Feb. 09	Bruker Corporation Announces the Launch of iNTApharma	CI

Transcript : Bruker Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09

Published on 01/12/2026 at 01:50 pm EST - Modified on 01/12/2026 at 03:35 pm EST

S&P Capital IQ

Presenter Speech
Casey Woodring (Analysts)

Life Sciences and Diagnostics team. Pleased to be joined by the management team of Bruker. This is a standard 40-minute session. We'll do a corporate

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bruker Corporation

Feb. 09	Chemspeed and SciY Announce Self-Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration	CI
Feb. 09	Bruker Corporation Announces the Launch of iNTApharma	CI
Jan. 26	Eclipse Bioinnovations, Inc. acquired Terrain Biosciences, Inc. from Magnetic Ventures and Bruker Corporation.	CI
Jan. 12	Bruker Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM
Jan. 12	(BRKR) Bruker Expects Q4 Revenue Range $965M - $970M, vs. FactSet Est of $958.3M	MT
Jan. 12	Bruker Corp expects 2026 organic revenue growth flat to low-single digits	RE
Jan. 09	Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for Mri	CI
Jan. 09	Bruker Unit Receives $500 Million in Orders for Superconductors	MT
Jan. 08	Bruker Acquires Complete Ownership of Tofwerk	MT
Jan. 07	Bruker Corporation acquired remaining majority stake Tofwerk AG.	CI
Dec. 22	Cellens Inc. announced that it has received $6.5 million in funding from a group of investors	CI
Dec. 22	Ri Research Instruments announces major orders for enabling technology for ELI-NP	RE
Dec. 22	HEDGE FLOW-Hedge funds short healthcare providers as subsidies debate intensifies	RE
Dec. 18	Abcellera and Bruker reach global settlement of patent litigation	RE
Dec. 18	AbCellera Biologics Says Bruker to Pay $36 Million Upfront in Patent Litigation Settlement	MT
Dec. 15	Bruker Corporation Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 04:00 PM
Dec. 10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT
Dec. 10	Bruker Receives $25 Million in European Orders for High-Performance Magnetic Resonance Systems	MT
Dec. 10	Bruker Corporation Receives Orders For High-Performance Magnetic Resonance Systems From École Normale Supérieure, Max Planck Institute For Solid-State Research, And Institut Européen De Chimie Et Biologie	CI
Dec. 10	Bruker Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-10-2025 10:00 AM
Dec. 08	Bruker Announces the Addition of Jack Phillips to Its Board of Directors, Effective January 1, 2026	CI
Nov. 24	Bruker Corporation acquired AST Revolution, LLC from Indaba Capital Management, L.P.	CI
Nov. 24	Bruker Buys AST Revolution	MT
Nov. 20	Rothschild & Co Redburn Initiates Coverage on Bruker With Buy Rating, $60 Price Target	MT
Nov. 04	Bruker Corporation Approves Quarterly Common Stock Dividend, Payable on January 2, 2026	CI